微电生理涨2.03%，成交额1.13亿元，主力资金净流入267.22万元

Core Viewpoint - Microelectrophysiology has shown a significant increase in stock price and trading volume, indicating positive market sentiment and potential growth in the medical device sector [1][2]. Company Overview - Shanghai Microelectrophysiology Medical Technology Co., Ltd. was established on August 31, 2010, and went public on August 31, 2022. The company specializes in the research, development, production, and sales of innovative medical devices in the field of electrophysiological intervention and ablation therapy [1]. - The company's revenue composition includes catheter products (71.77%), other products (20.22%), equipment (7.24%), and leasing services (0.77%) [1]. Financial Performance - For the period from January to September 2025, Microelectrophysiology achieved a revenue of 336 million yuan, representing a year-on-year growth of 15.65%. The net profit attributable to shareholders was 41.92 million yuan, with a slight increase of 0.46% year-on-year [2]. Stock Performance - As of November 5, the stock price of Microelectrophysiology increased by 31.99% year-to-date, with a 9.88% rise over the last five trading days, 13.56% over the last 20 days, and 12.84% over the last 60 days [1]. - The stock was trading at 25.13 yuan per share, with a market capitalization of 11.826 billion yuan [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders increased to 9,580, while the average number of tradable shares per person decreased by 8.26% to 13,033 shares [2]. - The largest shareholder is Huatai-PineBridge Innovation Medicine Mixed A, holding 4.7284 million shares, an increase of 308,600 shares from the previous period [3].